ProCE Banner Activity

Short-Course Glecaprevir/Pibrentasvir Plus Ezetimibe Prevents HCV Transmission During Transplantation From HCV-Infected Donors

Slideset Download
Conference Coverage
This small study showed that a short preemptive course of GLE/PIB + EZE given pre- and post-transplant prevented HCV transmission in all HCV-uninfected patients who received organs from HCV-infected donors.

Released: November 16, 2019

Expiration: November 14, 2020

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie

Gilead Sciences, Inc.

Intercept Pharmaceuticals